Smith Michael Alexander sold $173K of INSM
Smith Michael Alexander (Chief Legal Officer) sold 1,806 shares of INSMED Inc (INSM) at $95.82 ($0.17M total) on 2026-06-22 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure confirms an officer-level open-market sale of $173,050.92 worth of INSM shares, executed under a pre-arranged 10b5-1 plan.
Market read
This is a routine insider sale filing with limited incremental information for trading decisions.
What to watch
Traders may over-weight single insider sales; the more informative signal would be repeated sales across multiple insiders or changes in plan parameters, which are not provided here.
Background
The article is an SEC Form 4 insider transaction disclosure for INSMED Inc.
Ticker impact
INSMED Form 4 shows Chief Legal Officer Michael Alexander sold 1,806 shares at $95.82 under a 10b5-1 plan.
Likely minimal, short-lived impact unless follow-on selling accelerates.
The filing is a scheduled open-market sale under a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary sales.
Market effects
No sector-level implications; this is company-specific insider transaction disclosure.
None indicated.
None indicated.
Counterpoint
Because it is a 10b5-1 plan, the sale may reflect liquidity/compensation mechanics rather than bearish expectations.
Key entities
- issuerINSMED Inc
Company whose insider transaction is disclosed on Form 4.
- insiderMichael Alexander Smith
Chief Legal Officer who sold shares.
